Reckitt Benckiser Group (RKT) Share Price, News & Analysis

Company Overview

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands. The company also offers home fragrances and devices; water softeners; home cleaning products; dish washes; toilet cleaners; disinfecting sprays wipes, laundry sanitisers, and others; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands. In addition, it provides nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. The company was founded in 1819 and is headquartered in Slough, the United Kingdom.

Key Stats

• Today's Range: 4,495 to 4,577
• 50-Day Range: 4,093 to 4,667
• 52-Week Range: 4,034 to 6,006
• Volume: 5.14 million shs
• Average Volume: 3.57 million shs
• Market Capitalization: £31.35 billion
• P/E Ratio: 2,080.18
• Dividend Yield: 4.34%
• Price Target: GBX 4,800
• Consensus Rating: Hold

Reckitt Benckiser Group Stock Analysis - MarketRank™

Reckitt Benckiser Group scored higher than 4% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Reckitt Benckiser Group has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 4 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Reckitt Benckiser Group has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Reckitt Benckiser Group is 2,080.18, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 136.66.

Price to Earnings Ratio vs. Sector

The P/E ratio of Reckitt Benckiser Group is 2,080.18, which means that it is trading at a more expensive P/E ratio than the Consumer Defensive sector average P/E ratio of about 207.52.

Price to Earnings Growth Ratio

Reckitt Benckiser Group has a PEG Ratio of 2.37. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Reckitt Benckiser Group has a P/B Ratio of 3.91. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for RKT.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Reckitt Benckiser Group is a leading dividend payer. It pays a dividend yield of 4.34%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Reckitt Benckiser Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Reckitt Benckiser Group is 9,032.26%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for RKT.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Reckitt Benckiser Group this week, compared to 1 article on an average week.

Search Interest

Only 19 people have searched for RKT on MarketBeat in the last 30 days. This is a decrease of -37% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Reckitt Benckiser Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 0.07% of the stock of Reckitt Benckiser Group is held by insiders.

Percentage Held by Institutions

60.62% of the stock of Reckitt Benckiser Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

RKT Stock Analysis - Frequently Asked Questions

How have RKT shares performed this year?

Reckitt Benckiser Group's stock was trading at GBX 5,420 on January 1st, 2024. Since then, RKT shares have decreased by 16.7% and is now trading at GBX 4,514.
View the best growth stocks for 2024 here.

How do I buy shares of Reckitt Benckiser Group?

Shares of RKT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Company Calendar

• Ex-Dividend for 9/13 Dividend: 8/01/2024
• Dividend Payable: 9/13/2024
• Today: 9/20/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Consumer Defensive
• Industry: Household & Personal Products
• Sub-Industry: Banking
• Current Symbol: LON:RKT
• CUSIP: N/A
• CIK: N/A
• Web: www.reckitt.com
• Phone: 44 17 5321 7800
• Fax: N/A
• Employees: 26,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 4,800
• High Stock Price Target: GBX 5,200
• Low Stock Price Target: GBX 4,400
• Potential Upside/Downside: +6.3%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 4 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 2.17
• Trailing P/E Ratio: 2,080.18
• Forward P/E Ratio: 13.55
• P/E Growth: 2.37
• Net Income: £1.54 billion
• Net Margins: 10.78%
• Pretax Margin: N/A
• Return on Equity: 17.91%
• Return on Assets: 7.51%

Debt

• Debt-to-Equity Ratio: 109.95
• Current Ratio: 0.69
• Quick Ratio: 0.46

Sales & Book Value

• Annual Sales: £14.33 billion
• Price / Sales: 2.19
• Cash Flow: GBX 138.03 per share
• Price / Cash Flow: 32.70
• Book Value: GBX 1,155 per share
• Price / Book: 3.91

Miscellaneous

• Outstanding Shares: 694,570,000
• Free Float: N/A
• Market Cap: £31.35 billion
• Optionable: Not Optionable
• Beta: 0.09